Stock CPMD CANNAPHARMARX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CannaPharmaRX, Inc.

Equities

CPMD

US13765D1090

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 02:13:27 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.01 USD 0.00% Intraday chart for CannaPharmaRX, Inc. -9.09% +488.24%
Jun. 25 CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jun. 04 CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with ICAN Green S.A. de C.V to Create Distribution Network in the Latin Americas CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 30.53 45.81 21.89 1.584 2.569 0.7355
Enterprise Value (EV) 1 39.27 55.09 31.55 10.58 17.09 13.67
P/E ratio -9.87 x -1.92 x -1 x -0.11 x -0.25 x 0.17 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - -19,319,451 x -6,996,849 x -4,045,924 x -3,476,206 x -9,445,122 x
EV / FCF - -109,622,562 x 4,459,259 x -2,549,745 x 44,580,261 x -10,609,425 x
FCF Yield - -0% 0% -0% 0% -0%
Price to Book -93 x 10.6 x -2.46 x -0.12 x -0.14 x -0.05 x
Nbr of stocks (in thousands) 17,961 36,354 44,668 122,298 256,950 432,647
Reference price 2 1.700 1.260 0.4900 0.0130 0.0100 0.001700
Announcement Date 4/3/19 5/27/20 4/14/21 4/15/22 9/1/23 5/16/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA - -2.851 -4.51 -2.614 -4.917 -1.447
EBIT 1 -0.5328 -2.98 -4.638 -2.616 -5.212 -1.575
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -3.094 -20.45 -19.89 -8.832 -8.531 3.688
Net income 1 -3.094 -20.45 -19.89 -8.832 -8.531 3.688
Net margin - - - - - -
EPS 2 -0.1723 -0.6560 -0.4887 -0.1183 -0.0404 0.009999
Free Cash Flow - -0.5025 7.076 -4.148 0.3834 -1.289
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/3/19 5/27/20 4/14/21 4/15/22 9/1/23 5/16/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 8.74 9.28 9.67 8.99 14.5 12.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - -3.255 x -2.143 x -3.44 x -2.954 x -8.937 x
Free Cash Flow - -0.5 7.08 -4.15 0.38 -1.29
ROE (net income / shareholders' equity) 495% -895% 1,008% 81.3% 56.4% -25%
ROA (Net income/ Total Assets) - -14.3% -23.4% -36.9% -118% -10.9%
Assets 1 - 143.4 84.96 23.93 7.24 -33.87
Book Value Per Share 2 -0.0200 0.1200 -0.2000 -0.1100 -0.0700 -0.0400
Cash Flow per Share 2 0.0200 0 0.0100 0 0 0
Capex - 0.05 - 0.01 0.12 0.08
Capex / Sales - - - - - -
Announcement Date 4/3/19 5/27/20 4/14/21 4/15/22 9/1/23 5/16/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CANNAPHARMARX, INC. Stock CannaPharmaRX, Inc.
+488.24% 6.56M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.66% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+4.21% 230B
NOVARTIS AG Stock Novartis AG
+17.90% 228B
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CPMD Stock
  4. Financials CannaPharmaRX, Inc.